Logotype for Sensient Technologies Corporation

Sensient (SXT) Q2 2026 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Sensient Technologies Corporation

Q2 2026 earnings summary

4 Aug, 2026

Executive summary

  • Q2 2026 revenue grew 11.6% year-over-year to $462.1 million, with local currency revenue up 9.9%.

  • Adjusted EBITDA increased 22.7% to $98.2 million, and adjusted diluted EPS rose 25.5% to $1.20; diluted EPS up 36.4%.

  • Strong performance was driven by natural color conversions, new sales wins, favorable pricing, and operating leverage across all segments.

  • Management expressed strong confidence in continued momentum for the remainder of 2026.

  • Portfolio Optimization Plan completed, delivering $8M in annual cost savings and no related costs in 2026.

Financial highlights

  • Operating income for Q2 2026 was $76.7 million (16.6% margin), up 32.9% year-over-year.

  • Adjusted EBITDA for Q2 2026 was $98.2 million, up 22.7% year-over-year; adjusted EBITDA margin improved to 21.3%.

  • Net earnings for Q2 2026 were $51.4 million, up 36.6% year-over-year.

  • Gross margin improved to 37.4% in Q2 2026 from 34.5% in Q2 2025, aided by higher volumes, pricing, and $4.8M–$5M in tariff refunds.

  • Cash flow from operations was $34.8 million for the first half; capital expenditures were $67.5 million YTD.

Outlook and guidance

  • Full-year 2026 local currency revenue expected to grow high single to low double digits.

  • Adjusted EBITDA and EPS projected to grow mid to high teens; GAAP diluted EPS guidance raised to $4.10–$4.20.

  • Capital expenditures for 2026 expected at $150–$170 million, trending toward the high end.

  • No further significant tariff refunds anticipated; incremental tariff costs expected but offset by pricing.

  • Effective tax rate expected to remain near 25%.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more